| 2026-08-12 | Press release | Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg |
| 2026-07-31 | 10-Q | Form 10-Q for the quarter ended Jun 27 |
| 2026-07-23 | Supplement | GAAP/Non-GAAP Reconciliation and Financial Package · Q2 2026 |
| 2026-07-23 | Press release | Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday · Q2 2026 |
| 2026-07-23 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-23 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-09 | Press release | Thermo Fisher Scientific Announces Quarterly Dividend |
| 2026-06-15 | Press release | Thermo Fisher Scientific Announces Quarterly Dividend |
| 2026-05-26 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-20 | Press release | Thermo Fisher Scientific to Host Investor Day |
| 2026-05-01 | 10-Q | Form 10-Q for the quarter ended Mar 28 |
| 2026-04-23 | Press release | Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday · Q1 2026 |
| 2026-04-23 | Supplement | GAAP/Non-GAAP Reconciliation and Financial Package · Q1 2026 |
| 2026-04-23 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-23 | Transcript | Q1 FY26 earnings call transcript |
| 2026-04-07 | Proxy | Definitive proxy statement |
| 2026-03-27 | Annual report | 2025 Annual Report |
| 2026-03-24 | Press release | Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc |
| 2026-03-24 | 8-K | Form 8-K, Item 8.01 |
| 2026-03-03 | Press release | Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference |
| 2026-02-26 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-25 | Press release | Thermo Fisher Scientific Increases Quarterly Dividend |
| 2026-02-12 | Press release | Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes |
| 2026-02-12 | 8-K | Form 8-K, Item 1.01 |
| 2026-01-30 | Transcript | Q4 FY25 earnings call transcript |
| 2026-01-29 | Press release | Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 29, 2026 |
| 2026-01-29 | 8-K | Form 8-K, Item 2.02 results |
| 2026-01-13 | Press release | Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference |
| 2026-01-12 | Press release | Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance |
| 2026-01-12 | 8-K | Form 8-K, Item 5.02 |
| 2025-12-01 | 8-K | Form 8-K, Item 1.01 |
| 2025-10-31 | 10-Q | Form 10-Q for the quarter ended Sep 27 |
| 2025-10-29 | 8-K | Form 8-K, Item 8.01 |
| 2025-10-23 | Transcript | Q3 FY25 earnings call transcript |
| 2025-10-22 | 8-K | Form 8-K, Item 2.02 results |
| 2025-10-07 | 8-K | Form 8-K, Item 1.01 |
| 2025-09-02 | 8-K | Form 8-K, Item 8.01 |
| 2025-08-01 | 10-Q | Form 10-Q for the quarter ended Jun 28 |
| 2025-07-23 | Press release | Thermo Fisher Scientific Reports Second Quarter 2025 Results |
| 2025-07-23 | 8-K | Form 8-K, Item 2.02 results |